SAM
IOVA icon

Shell Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Shell Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$10K Sell
4,454
-1,464
-25% -$3.46K ﹤0.01% 1114
2025
Q2 		$10K Hold
5,918
– – ﹤0.01% 1252
2025
Q1 		$20K Sell
5,918
-246
-4% -$1.27K ﹤0.01% 1227
2024
Q4 		$46K Sell
6,164
-82
-1% -$760 ﹤0.01% 1190
2024
Q3 		$59K Buy
+6,246
New +$59.2K ﹤0.01% 1159
2024
Q1 		$50K Sell
6,284
-677
-10% -$7.88K ﹤0.01% 1157
2023
Q4 		$57K Sell
6,961
-2,091
-23% -$10.9K ﹤0.01% 1156
2023
Q3 		$41K Sell
9,052
-142
-2% -$927 ﹤0.01% 1211
2023
Q2 		$65K Sell
9,194
-53
-0.6% -$379 ﹤0.01% 1190
2023
Q1 		$56K Sell
9,247
-33
-0.4% -$228 ﹤0.01% 1173
2022
Q4 		$59K Sell
9,280
-1,884
-17% -$14.7K ﹤0.01% 1245
2022
Q3 		$107K Sell
11,164
-2,924
-21% -$33.7K ﹤0.01% 1210
2022
Q2 		$156K Buy
14,088
+23
+0.2% +$301 ﹤0.01% 1179
2022
Q1 		$234K Sell
14,065
-2,082
-13% -$32.2K 0.01% 1133
2021
Q4 		$308K Buy
16,147
+78
+0.5% +$1.72K 0.01% 1099
2021
Q3 		$396K Sell
16,069
-690
-4% -$16.3K 0.01% 969
2021
Q2 		$436K Buy
+16,759
New +$436K 0.01% 977
2021
Q1 		– Sell
-12,574
Closed -$583K – 1471
2020
Q4 		$583K Buy
12,574
+6,291
+100% +$250K 0.01% 729
2020
Q3 		$207K Buy
+6,283
New +$193K ﹤0.01% 1035

Other funds holding IOVA

MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Shell Asset Management's IOVA Position: Q3 2025 in Review

Shell Asset Management reduced its Iovance Biotherapeutics (IOVA) stake by 25% in Q3 2025, selling an estimated $3.46K and leaving 4,454 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

Shell Asset Management first reported a position in IOVA in Q3 2020 and has held it in 19 quarters since. The position peaked at $583K in Q4 2020. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2025.

  • Shell Asset Management held 4,454 shares of Iovance Biotherapeutics worth $10K as of Q3 2025.
  • Shell Asset Management sold 1,464 Iovance Biotherapeutics shares in Q3 2025, an estimated $3.46K.
  • Iovance Biotherapeutics made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1114 holding.
  • Shell Asset Management first reported a position in Iovance Biotherapeutics in Q3 2020 and has held it in 19 quarters since.
  • Shell Asset Management's Iovance Biotherapeutics position peaked at $583K in Q4 2020.
  • 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.